{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:17:55Z","timestamp":1792657075903,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T00:00:00Z","timestamp":1325289600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12105-011-0325-4","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T01:40:19Z","timestamp":1325209219000},"page":"290-295","source":"Crossref","is-referenced-by-count":53,"title":["Mucosal Pigmentation Caused by Imatinib: Report of Three Cases"],"prefix":"10.1007","volume":"6","author":[{"given":"Chia-Cheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman M.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart F.","family":"Blaeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid J.","family":"Dehni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadru P.","family":"Kabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Toner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Bin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,31]]},"reference":[{"issue":"14","key":"325_CR1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New Engl J Med. 2001;344(14):1031\u20137.","journal-title":"New Engl J Med"},{"issue":"9","key":"325_CR2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","volume":"346","author":"H Kantarjian","year":"2002","unstructured":"Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. New Engl J Med. 2002;346(9):645\u201352.","journal-title":"New Engl J Med"},{"issue":"9","key":"325_CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","volume":"346","author":"DG Savage","year":"2002","unstructured":"Savage DG, Antman KH. Imatinib mesylate\u2014a new oral targeted therapy. New Engl J Med. 2002;346(9):683\u201393.","journal-title":"New Engl J Med"},{"issue":"2","key":"325_CR4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdh068","volume":"15","author":"B Arora","year":"2004","unstructured":"Arora B, Kumar L, Sharma A, Wadhwa J, Kochupillai V. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate. Ann Oncol. 2004;15(2):358\u20139.","journal-title":"Ann Oncol"},{"key":"325_CR5","doi-asserted-by":"crossref","unstructured":"Resende RG, Teixeira RG, Vasconcelos FD, Silva ME, Abreu MH, Gomez RS. Imatinib-associated hyperpigmentation of the palate in post-HSCT patient. J Craniomaxillofac Surg. 2011. doi: 10.1016\/j.jcms.2011.07.010 .","DOI":"10.1016\/j.jcms.2011.07.010"},{"issue":"8","key":"325_CR6","first-page":"24","volume":"100","author":"DM Lewis","year":"2009","unstructured":"Lewis DM. Diffuse pigmentation of the palate. J Okla Dent Assoc. 2009;100(8):24\u20135.","journal-title":"J Okla Dent Assoc"},{"issue":"5","key":"325_CR7","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.tripleo.2010.11.006","volume":"111","author":"U Mattsson","year":"2011","unstructured":"Mattsson U, Halbritter S, Morner Serikoff E, Christerson L, Warfvinge G. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(5):e12\u20136.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"325_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-3083.2008.02706.x","volume":"23","author":"T McPherson","year":"2009","unstructured":"McPherson T, Sherman V, Turner R. Imatinib-associated hyperpigmentation, a side effect that should be recognized. J Eur Acad Dermatol Venereol. 2009;23(1):82\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2 Pt 1","key":"325_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(95)90134-5","volume":"32","author":"JL Arbiser","year":"1995","unstructured":"Arbiser JL, Moschella SL. Clofazimine: a review of its medical uses and mechanisms of action. J Am Acad Dermatol. 1995;32(2 Pt 1):241\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"325_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(81)70072-0","volume":"5","author":"RD Granstein","year":"1981","unstructured":"Granstein RD, Sober AJ. Drug- and heavy metal\u2013induced hyperpigmentation. J Am Acad Dermatol. 1981;5(1):1\u201318.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"325_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(81)70065-3","volume":"4","author":"FC Koranda","year":"1981","unstructured":"Koranda FC. Antimalarials. J Am Acad Dermatol. 1981;4(6):650\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"325_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/moe.2000.106340","volume":"90","author":"CL Kleinegger","year":"2000","unstructured":"Kleinegger CL, Hammond HL, Finkelstein MW. Oral mucosal hyperpigmentation secondary to antimalarial drug therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(2):189\u201394.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"325_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tripleo.2008.07.022","volume":"107","author":"MA Lerman","year":"2009","unstructured":"Lerman MA, Karimbux N, Guze KA, Woo SB. Pigmentation of the hard palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):8\u201312.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"325_CR14","first-page":"61","volume":"48","author":"R Perusse","year":"1991","unstructured":"Perusse R, Morency R. Oral pigmentation induced by Premarin. Cutis. 1991;48(1):61\u20134.","journal-title":"Cutis"},{"key":"325_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1999.tb08663.x","volume":"885","author":"S Solomon","year":"1999","unstructured":"Solomon S. POMC-derived peptides and their biological action. Ann NY Acad Sci. 1999;885:22\u201340.","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"325_CR16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-0749.2003.00055.x","volume":"16","author":"B Wehrle-Haller","year":"2003","unstructured":"Wehrle-Haller B. The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res. 2003;16(3):287\u201396.","journal-title":"Pigment Cell Res"},{"issue":"6","key":"325_CR17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.tripleo.2003.11.006","volume":"97","author":"NS Treister","year":"2004","unstructured":"Treister NS, Magalnick D, Woo SB. Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(6):718\u201325.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"325_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.0307-6938.2001.00947.x","volume":"27","author":"B Kumar","year":"2002","unstructured":"Kumar B, Saraswat A, Kaur I. Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients. Clin Exp Dermatol. 2002;27(1):8\u201313.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"325_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.0736-8046.2004.21207.x","volume":"21","author":"M Issaivanan","year":"2004","unstructured":"Issaivanan M, Mitu PS, Manisha C, Praveen K. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review. Pediatr Dermatol. 2004;21(2):124\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"3\u20134","key":"325_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/09537100400020179","volume":"16","author":"ML Randi","year":"2005","unstructured":"Randi ML, Ruzzon E, Tezza F, Luzzatto G, Fabris F. Toxicity and side effects of hydroxyurea used for primary thrombocythemia. Platelets. 2005;16(3\u20134):181\u20134.","journal-title":"Platelets"},{"issue":"7","key":"325_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-4362.1992.tb02689.x","volume":"31","author":"JD Hendrix Jr","year":"1992","unstructured":"Hendrix JD Jr, Greer KE. Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol. 1992;31(7):458\u201366.","journal-title":"Int J Dermatol"},{"issue":"4","key":"325_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2257.1992.tb00111.x","volume":"14","author":"PR Kelsey","year":"1992","unstructured":"Kelsey PR. Multiple longitudinal pigmented nail bands during hydroxyurea therapy. Clin Lab Haematol. 1992;14(4):337\u20138.","journal-title":"Clin Lab Haematol"},{"issue":"5","key":"325_CR23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tripleo.2007.07.047","volume":"105","author":"M Meleti","year":"2008","unstructured":"Meleti M, Vescovi P, Mooi WJ, van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(5):606\u201316.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"325_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0749.2004.00206.x","volume":"18","author":"S Schepper De","year":"2005","unstructured":"De Schepper S, Boucneau J, Lambert J, Messiaen L, Naeyaert JM. Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment Cell Res. 2005;18(1):13\u201324.","journal-title":"Pigment Cell Res"},{"issue":"5","key":"325_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000023467","volume":"52","author":"IS Kim","year":"1999","unstructured":"Kim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, et al. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Hormone Res. 1999;52(5):235\u201340.","journal-title":"Hormone Res"},{"issue":"2","key":"325_CR26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00438-005-1124-y","volume":"273","author":"N Lin-Marq","year":"2005","unstructured":"Lin-Marq N, Borel C, Antonarakis SE. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics. 2005;273(2):184\u201396.","journal-title":"Mol Genet Genomics"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-011-0325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12105-011-0325-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-011-0325-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:07:05Z","timestamp":1559434025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12105-011-0325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,31]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s12105-011-0325-4","relation":{},"ISSN":["1936-055X","1936-0568"],"issn-type":[{"value":"1936-055X","type":"print"},{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,31]]}}}